CDH1 and Mental deterioration: APC/C inactivation has been found in AD models, Cdh1 targets being accumulated in the brain of AD patients, which promote neurodegeneration and cognitive decline through several mechanisms including cell cycle machinery activation, excitotoxicity, metabolism impairment, oxidative stress, and synaptic dysfunction (Figure 2), rendering this pathway as a suitable candidate to develop drugs for AD treatment.